Lifeline Scientific is organized around two business units: Organ Recovery Systems and Cell & Tissue Systems leveraging a common technology platform to serve important unmet needs in their respective fields of clinical transplantation and medical research.

 

Lifeline’s primary commercial focus is its LifePort^® Kidney Transporter product line. LifePort is designed to enhance human kidney donor organ preservation during transport from donor to recipient. LifePort addresses the global problem of human donor organ shortage and is marketed through the company’s Organ Recovery Systems business unit.